Literature DB >> 26766527

Patterns of Extragenital Chlamydia and Gonorrhea in Women and Men Who Have Sex With Men Reporting a History of Receptive Anal Intercourse.

Claire S Danby1, Lisa A Cosentino, Lorna K Rabe, Carol L Priest, Khrystine C Damare, Ingrid S Macio, Leslie A Meyn, Harold C Wiesenfeld, Sharon L Hillier.   

Abstract

BACKGROUND: Screening for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) in men who have sex with men is risk based. Despite high frequencies of oral and receptive anal intercourse (RAI) among women, extragenital screening is not recommended.
METHODS: Women (n = 175) and men who have sex with men (n = 224) primarily recruited from a sexually transmitted infection clinic reporting a lifetime history of RAI completed a structured questionnaire and clinician-collected swab samples from the rectum, pharynx, vagina (women), and urine (men). CT and GC were detected using 2 commercial nucleic acid amplification tests (Aptima Combo 2; Hologic, Inc, Bedford, MA; Xpert CT/NG, Cepheid Innovation, Sunnyvale, CA).
RESULTS: The median age of the population was 26 years, 62% were white, and 88% were enrolled from a sexually transmitted disease clinic. Men were more likely than women to have GC (22.8% vs. 3.4%) and CT (21.9% vs. 12.6%). In men versus women, GC was detected in 16.5% versus 2.3% of pharyngeal swabs, 11.6% versus 2.3% of rectal swabs, and 5.4% versus 2.9% of urine samples or vaginal swabs. C. trachomatis was detected in 2.2% versus 1.7% of pharyngeal swabs, 17.4% versus 11.4% of rectal swabs, and 4.5% versus 10.3% for urogenital sites in men versus women. Overall 79.6% of CT and 76.5% of GC in men and 18.2% of CT and 16.7% of GC in women were detected only in the pharynx or rectum.
CONCLUSION: Reliance on urogenital screening alone misses most of GC and CT in men and more than 15% of infections in women reporting RAI.

Entities:  

Mesh:

Year:  2016        PMID: 26766527      PMCID: PMC4955797          DOI: 10.1097/OLQ.0000000000000384

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  29 in total

1.  Evaluation of APTIMA Combo 2 for cross-reactivity with oropharyngeal Neisseria species and other microorganisms.

Authors:  Zenzo Nagasawa; Yurika Ikeda-Dantsuji; Toshihiro Niwa; Hideo Miyakoshi; Ariaki Nagayama
Journal:  Clin Chim Acta       Date:  2010-02-04       Impact factor: 3.786

2.  Culture of non-genital sites increases the detection of gonorrhea in women.

Authors:  Courtney M Giannini; Hye K Kim; Jonathan Mortensen; Joel Mortensen; Keith Marsolo; Jill Huppert
Journal:  J Pediatr Adolesc Gynecol       Date:  2010-08       Impact factor: 1.814

3.  Sexual behavior, sexual attraction, and sexual identity in the United States: data from the 2006-2008 National Survey of Family Growth.

Authors:  Anjani Chandra; William D Mosher; Casey Copen; Catlainn Sionean
Journal:  Natl Health Stat Report       Date:  2011-03-03

4.  Prevalence and characteristics of rectal chlamydia and gonorrhea cases among men who have sex with men after the introduction of nucleic acid amplification test screening at 2 Canadian sexually transmitted infection clinics.

Authors:  Jennifer Gratrix; Ameeta E Singh; Joshua Bergman; Cari Egan; Justin McGinnis; Steven J Drews; Ron Read
Journal:  Sex Transm Dis       Date:  2014-10       Impact factor: 2.830

5.  Female users of internet-based screening for rectal STIs: descriptive statistics and correlates of positivity.

Authors:  Jessica Ladd; Yu-Hsiang Hsieh; Mathilda Barnes; Nicole Quinn; Mary Jett-Goheen; Charlotte A Gaydos
Journal:  Sex Transm Infect       Date:  2014-03-06       Impact factor: 3.519

6.  Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures.

Authors:  Joshua D Trebach; C Patrick Chaulk; Kathleen R Page; Susan Tuddenham; Khalil G Ghanem
Journal:  Sex Transm Dis       Date:  2015-05       Impact factor: 2.830

7.  Rectal infections with chlamydia and gonorrhoea in women attending a multiethnic sexually transmitted diseases urban clinic.

Authors:  T Hunte; M Alcaide; J Castro
Journal:  Int J STD AIDS       Date:  2010-12       Impact factor: 1.359

8.  Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections.

Authors:  Lisa A Cosentino; Tracy Campbell; Abi Jett; Ingrid Macio; Tracy Zamborsky; Ross D Cranston; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2012-04-04       Impact factor: 5.948

9.  Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations--five cities, United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-07-10       Impact factor: 17.586

10.  Rectal chlamydia--a reservoir of undiagnosed infection in men who have sex with men.

Authors:  N T Annan; A K Sullivan; A Nori; P Naydenova; S Alexander; A McKenna; B Azadian; S Mandalia; M Rossi; H Ward; N Nwokolo
Journal:  Sex Transm Infect       Date:  2009-01-28       Impact factor: 3.519

View more
  18 in total

1.  Body Parts Matter: Social, Behavioral, and Biological Considerations for Urethral, Pharyngeal, and Rectal Gonorrhea and Chlamydia Screening Among MSM in Lima, Peru.

Authors:  Ryan Colby Passaro; Eddy R Segura; Amaya Perez-Brumer; Jeanne Cabeza; Silvia M Montano; Jordan E Lake; Jorge Sanchez; Javier R Lama; Jesse L Clark
Journal:  Sex Transm Dis       Date:  2018-09       Impact factor: 2.830

2.  Rectal Chlamydia trachomatis and Neisseria gonorrhoeae Infections Among Women Reporting Anal Intercourse.

Authors:  Eloisa Llata; Jim Braxton; Lenore Asbel; Joan Chow; Lindsay Jenkins; Ryan Murphy; Preeti Pathela; Christina Schumacher; Elizabeth Torrone
Journal:  Obstet Gynecol       Date:  2018-09       Impact factor: 7.661

3.  Meta-analysis of the Cepheid Xpert® CT/NG assay for extragenital detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections.

Authors:  Claire C Bristow; Sheldon R Morris; Susan J Little; Sanjay R Mehta; Jeffrey D Klausner
Journal:  Sex Health       Date:  2019-08       Impact factor: 2.706

Review 4.  Neisseria gonorrhoeae host adaptation and pathogenesis.

Authors:  Sarah Jane Quillin; H Steven Seifert
Journal:  Nat Rev Microbiol       Date:  2018-02-12       Impact factor: 60.633

5.  Point-by-Point Progress: Gonorrhea Point of Care Tests.

Authors:  Charlotte A Gaydos; Johan H Melendez
Journal:  Expert Rev Mol Diagn       Date:  2020-06-30       Impact factor: 5.225

6.  Comparative Evaluation of 2 Nucleic Acid Amplification Tests for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae at Extragenital Sites.

Authors:  Claire C Bristow; Mark R McGrath; Adam C Cohen; Laura J Anderson; Kristie K Gordon; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2017-07       Impact factor: 2.830

7.  Use of Nucleic Acid Amplification Testing for Diagnosis of Extragenital Sexually Transmitted Infections.

Authors:  Lisa A Cosentino; Claire S Danby; Lorna K Rabe; Ingrid Macio; Leslie A Meyn; Harold C Wiesenfeld; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2017-07-05       Impact factor: 5.948

Review 8.  Galectins as potential therapeutic targets in STIs in the female genital tract.

Authors:  Agustin L Lujan; Diego O Croci; Gabriel A Rabinovich; Maria T Damiani
Journal:  Nat Rev Urol       Date:  2022-02-01       Impact factor: 14.432

9.  Detection of Three Sexually Transmitted Infections by Anatomic Site: Evidence From an Internet-Based Screening Program.

Authors:  Nikki N Jordan; Mary Jett-Goheen; Yu-Hsiang Hsieh; Joel C Gaydos; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2020-04       Impact factor: 3.868

10.  Sexually Transmitted Infection Positivity Among Adolescents With or at High-Risk for Human Immunodeficiency Virus Infection in Los Angeles and New Orleans.

Authors:  Chelsea L Shannon; Erin M Keizur; Anne Fehrenbacher; Drew Wood-Palmer; Wilson Ramos; Maryann Koussa; Jasmine Fournier; Sung-Jae Lee; Dhara Patel; Whitney N Akabike; Sue Ellen Abdalian; Mary Jane Rotheram-Borus; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2019-11       Impact factor: 3.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.